| scholarly article | Q13442814 |
| P50 | author | Benjamin Linas | Q56655086 |
| P2093 | author name string | Wei Huang | |
| Judith I Tsui | |||
| Katelyn J Carey | |||
| P2860 | cites work | Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews | Q24630669 |
| Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis | Q26822903 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience | Q33845768 | ||
| Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus | Q34044333 | ||
| Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system | Q34432627 | ||
| Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients | Q35691511 | ||
| Rate and predictors of treatment prescription for hepatitis C. | Q35761383 | ||
| Quality of hepatitis C care at an urban tertiary care medical center | Q35971578 | ||
| A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users | Q36298213 | ||
| Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment | Q36476423 | ||
| Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance | Q36562909 | ||
| Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients | Q37142229 | ||
| Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program | Q37216987 | ||
| Limited uptake of hepatitis C treatment among injection drug users | Q37238205 | ||
| Hepatitis C treatment for injection drug users: a review of the available evidence | Q37546106 | ||
| Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers. | Q38064495 | ||
| The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. | Q39304230 | ||
| Public health impact of antiviral therapy for hepatitis C in the United States | Q39939298 | ||
| Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States | Q40786866 | ||
| A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment | Q42219124 | ||
| Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study | Q42280287 | ||
| Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy | Q42619415 | ||
| Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment | Q42658701 | ||
| Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. | Q42978282 | ||
| Hepatitis C virus prevention, care, and treatment: from policy to practice | Q42981529 | ||
| The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users | Q44163628 | ||
| Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy | Q44342144 | ||
| The impact of injecting drug use status on hepatitis C-related referral and treatment | Q45193444 | ||
| Methadone maintenance and hepatitis C virus infection among injecting drug users | Q45759328 | ||
| Referral for chronic hepatitis C treatment from a drug dependency treatment setting. | Q50574950 | ||
| Low Risk for Hepatitis C Seroconversion in Methadone Maintenance Treatment | Q59357083 | ||
| FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest | Q62658359 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | clinical psychology | Q199906 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 54-59 | |
| P577 | publication date | 2016-02-13 | |
| P1433 | published in | Journal of Substance Abuse Treatment | Q15762042 |
| P1476 | title | Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders | |
| P478 | volume | 66 |
Search more.